Cite

    Chang, H. et al. (2017). Impact of epidermal growth factor receptor gene expression level on clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients taking first-line epidermal growth factor receptor–tyrosine kinase inhibitors. Tumor biology. 39 (3), p. . [Online].